Tirzepatide is a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://rajanfcrp007022.uzblog.net/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist-54173959